4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
主营:原厂直采,平行进口,授权代理(蚂蚁淘为您服务)
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > Others > velsicol123/Acrylates copolymer/25133-97-5
商品详细velsicol123/Acrylates copolymer/25133-97-5
velsicol123/Acrylates copolymer/25133-97-5
velsicol123/Acrylates copolymer/25133-97-5
商品编号: 25133-97-5
品牌: velsicol123
市场价: ¥0.00
美元价: 0.00
产地: United States
产品分类: 重组蛋白
公司分类: Others
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍

Acrylates copolymer;2-Propenoic acid, 2-methyl-, polymer with ethyl 2-propenoate and methyl 2-methyl-2-propenoate;acrylic acid terpolymer, partial sod…

Acrylates copolymer;2-Propenoic acid, 2-methyl-, polymer with ethyl 2-propenoate and methyl 2-methyl-2-propenoate;acrylic acid terpolymer, partial sodium salts;methyl methacrylate/ ethyl acrylate/ methacrylic acid pol.;Acrylic acid-acrylate polymer
品牌介绍
Velsicol Chemical LLC is the technology leader in industrial intermediates based primarily on cyclopentadiene including hexachlorocyclopentadiene and chlorendic anhydride. Since 1931, Velsicol has been known around the world for its quality products. Our standard is conformance to customer requirements 100% of the time. To help ensure consistent product quality throughout our operations, every Velsicol-owned manufacturing facility is certified under ISO 9002. Additionally, we have committed all our facilities to a continuing effort to improve its responsible management of chemicals.Velsicol employees are dedicated to the values of safety, quality, service, social responsibility and cost effectiveness. These values are demonstrated throughout our company in the actions of our people, the management systems we establish and the performance of our operations. Velsicol Chemical is a subsidiary of Arsenal Capital Partners. Arsenal Capital Partners is a private equity firm that makes investments in specialty industrial, healthcare and financial services companies. Arsenal invests in sectors where the firm has prior knowledge and experience, and targets businesses that have the potential for further value creation by working closely with management to accelerate growth and leverage the firm’s operational improvement capabilities. Arsenal currently has $800 million of committed equity capital under management and maintains offices in New York City and Shanghai, China. For additional information on Arsenal Capital Partners, please visit www.arsenalcapital.com.